Wir bedanken uns sehr herzlich bei unseren Sponsoren für die Unterstützung!


CYTIVA virtual half-day forum
Thursday, 29 September 2022 04:22
Half-day virtual event from Cytiva: How biotech startups and translational researchers can prepare to bring innovative treatments to patients Cytiva has invited several noteworthy colleagues from our industry to share their experience in an intimate online forum. Join guests from THT Biomaterials (Vienna, AT), Charité (Berlin, DE), Prime Vector Technologies (Tübingen, DE), and a few Cytiva mentors who will discuss the challenges, triumphs, and key considerations for the development and delivery of novel therapies to patients. In this virtual half-day forum, Cytiva invites industry leaders to share their experiences with overcoming obstacles and bringing novel therapies to patients. Join for guidance on what to expect on the translational journey along with how to avoid common pitfalls as you get started. The program will be presented in two sessions with a 20-minute intermission. It will end with a roundtable discussion where you will have the chance to ask the experts…
Published in
Allgemeine News
Life Sciences - Ausschreibung mit 31 Mio. € Budget gestartet
Wednesday, 28 September 2022 09:18
31 Millionen Euro Budget stehen im Rahmen der Life Sciences Ausschreibung 2022 für Forschungs- und Entwicklungsprojekte und Klinische Studien zur Verfügung. Die Förderobergrenzen der reinen Zuschuss-Förderung liegen bei € 500.000,- im Falle von Unternehmensprojekten, bei € 1.000.000 im Falle von Klinischen Studien. Eine Antragstellung ist laufend bis längstens 29.12.2022 (12 Uhr) möglich. https://www.ffg.at/ausschreibung/AustrianLifeSciences-2022
Published in
Allgemeine News
FEBS / EMBO Women in Science Award
Thursday, 22 September 2022 02:42
2023 FEBS / EMBO Women in Science Award nominations deadline is 15th October: https://www.febs.org/our-activities/awards/febs-embo-women-in-science-award/
Published in
Allgemeine News